The association between the presence of anti-interferon-γ autoantibodies and the onset of immunodeficiency with intracellular infections has been clearly established. No standard regimen to control the production of these pathogenic autoantibodies, apart from antimicrobial therapy to eliminate infections, contributes to the medical burden of this syndrome, which sometimes has a fatal outcome. In this review, we summarize the findings on anti-interferon-γ autoantibodies to facilitate further research and to provide guidance for treatment strategies.
BrowneSKBurbeloPDChetchotisakdPSuputtamongkolYKiertiburanakulSShawPAKirkJLJutivorakoolKZamanRDingLHsuAPPatelSYOlivierKNLulitanondVMootsikapunPAnunnatsiriSAngkasekwinaiNSathapatayavongsBHsuehPRShiehCCBrownMRThongnoppakhunWClaypoolRSampaioEPThepthaiCWaywaDDacombeCReizesYZelaznyAMSaleebPRosenLBMoAIadarolaMHollandSM.Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med2012;
367:725–34
2.
WongkulabPWipasaJChaiwarithRSupparatpinyoK.Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand. PLoS One2013;
8:e76371
3.
PoulinSCorbeilCNguyenMSt-DenisACoteLLe DeistFCarignanA.Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a case report. BMC Infect Dis2013;
13:24
4.
WengTPSyueLSLeeNY.Disseminated Mycobacterium szulgai infection in a patient with anti-interferon-gamma autoantibodies. IDCases2020;
21:e00848
5.
ChetchotisakdPAnunnatsiriSNithichanonALertmemongkolchaiG.Cryptococcosis in anti-interferon-gamma autoantibody-positive patients: a different clinical manifestation from HIV-infected patients. Jpn J Infect Dis2017;
70:69–74
6.
HongGHOrtega-VillaAMHunsbergerSChetchotisakdPAnunnatsiriSMootsikapunPRosenLBZerbeCSHollandSM.Natural history and evolution of anti-interferon-gamma autoantibody-associated immunodeficiency syndrome in Thailand and the United States. Clin Infect Dis2020;
71:53–62
7.
KampitakTSuwanpimolkulGBrowneSSuankratayC.Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature. Infection2011;
39:65–71
8.
LinCHChiCYShihHPDingJYLoCCWangSYKuoCYYehCFTuKHLiuSHChenHKHoCHHoMWLeeCHLaiHCKuCL.Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease. Nat Med2016;
22:994–1001
9.
WuUIHungCCChangSYJhongYTSunHYWangJTHsiehSMShengWHLiuWCChangSCChenYC.Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy. AIDS2017;
31:2557–9
10.
CarusoABonfantiCColombritaDDe FrancescoMDe RangoCForestiIGargiuloFGonzalesRGribaudoGLandolfoS.Natural antibodies to IFN-gamma in man and their increase during viral infection. J Immunol1990;
144:685–90
11.
DonEvan der MeideNEgorovVPutilovskiyMTarasovS.The level of natural autoantibodies to IFN-gamma in varicella infection treated with antiviral drug anaferon for children: a pilot study. Immunol Lett2020;
222:90–4
12.
AokiASakagamiTYoshizawaKShimaKToyamaMTanabeYMoroHAokiNWatanabeSKoyaTHasegawaTMorimotoKKurashimaAHoshinoYTrapnellBCKikuchiT.Clinical significance of interferon-γ neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease. Clin Infect Dis2018;
66:1239–45
13.
SahaBJyothi PrasannaSChandrasekarBNandiD.Gene modulation and immunoregulatory roles of interferon gamma. Cytokine2010;
50:1–14
14.
KrisnawatiDILiuYCLeeYJWangYTChenCLTsengPCLinCF.Functional neutralization of anti-IFN-gamma autoantibody in patients with nontuberculous mycobacteria infection. Sci Rep2019;
9:5682
15.
KrisnawatiDILiuYCLeeYJWangYTChenCLTsengPCShenTJLinCF.Blockade effects of anti-interferon- (IFN-) γ autoantibodies on IFN-γ-regulated antimicrobial immunity. J Immunol Res2019;
2019:1629258
16.
KampmannBHemingwayCStephensADavidsonRGoodsallAAndersonSNicolMSchölvinckERelmanDWaddellSLangfordPSheehanBSempleLWilkinsonKAWilkinsonRJRessSHibberdMLevinM.Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest2005;
115:2480–8
17.
HoflichCSabatRRosseauSTemmesfeldBSlevogtHDockeWDGrutzGMeiselCHalleEGobelUBVolkHDSuttorpN.Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium chelonae and burkholderia cocovenenans. Blood2004;
103:673–5
18.
DingLMoAJutivorakoolKPancholiMHollandSMBrowneSK.Determination of human anticytokine autoantibody profiles using a particle-based approach. J Clin Immunol2012;
32:238–45
19.
O'ConnellERosenLBLaRueRWFabreVMeliaMTAuwaerterPGHollandSMBrowneSK.The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-gamma autoantibodies. J Clin Immunol2014;
34:928–32
20.
HanitschLGLobelMMuller-RedetzkyHSchurmannMSuttorpNUnterwalderNMonnichUMeiselCWittkeKVolkHDScheibenbogenCKolschU.Late-onset disseminated Mycobacterium avium intracellulare complex infection (MAC), cerebral toxoplasmosis and salmonella sepsis in a German caucasian patient with unusual anti-interferon-gamma IgG1 autoantibodies. J Clin Immunol2015;
35:361–5
21.
WipasaJChaiwarithRChawansuntatiKPraparattanapanJRattanathammetheeKSupparatpinyoK.Characterization of anti-interferon-gamma antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms. Exp Biol Med2018;
243:621–6
22.
YasamutUThongkumWMoonmuangSSakkhachornphopSChaiwarithRPraparattanapanJWipasaJChawansuntatiKSupparatpinyoKLaiETayapiwatanaC.Neutralizing activity of anti-interferon-γ autoantibodies in adult-onset immunodeficiency is associated with their binding domains. Front Immunol2019;
10:1905
23.
TangBSChanJFChenMTsangOTMokMYLaiRWLeeRQueTLTseHLiIWToKKChengVCChanEYZhengBYuenKY.Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol2010;
17:1132–8
24.
PhoompoungPAnkasekwinaiNPithukpakornMFoongladdaSUmrodPSuktitipatBMahasirimongkolSKiertiburanakulSSuputtamongkolY.Factors associated with acquired anti IFN- gamma autoantibody in patients with nontuberculous mycobacterial infection. PLoS One2017;
12:e0176342
25.
NamkoongHAsakuraTIshiiMYodaSMasakiKSakagamiTIwasakiEYamagishiYKanaiTBetsuyakuTHasegawaN.First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies. New Microbes New Infect2019;
27:4–6
26.
YehYKDingJYKuCLChenWC.Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-gamma autoantibodies: a case report. BMC Infect Dis2019;
19:909
27.
HaseIMorimotoKSakagamiTIshiiYvan IngenJ.Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review. Diagn Microbiol Infect Dis2017;
88:308–15
28.
ChangPHChuangYC.Anti-interferon-gamma autoantibody-associated disseminated Mycobacterium abscessus infection mimicking parotid cancer with multiple metastases: a case report. Medicine2017;
96:e8118
29.
FuruyaHIkedaKMiyachiKNakamuraKSuzukiKFurutaSTamachiTHiroseKSakagamiTNakajimaH.SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNgamma autoantibody. Rheumatology2017;
56:1241–3
30.
LiewWKThoonKCChongCYTanNWHChengDTChanBSWNgMSYDasLArkachaisriTHuangCHKuanJLChaiLYAKohMJA.Juvenile-onset immunodeficiency secondary to anti-interferon-gamma autoantibodies. J Clin Immunol2019;
39:512–8
31.
QiuYZhangJLiBShuH.Bacillus cereus isolated from a positive bone tissue culture in a patient with osteolysis and high-titer anti-interferon-gamma autoantibodies: a case report. Medicine2019;
98:e17609
32.
ChiCYChuCCLiuJPLinCHHoMWLoWJLinPCChenHJChouCHFengJYFungCPSherYPLiCYWangJHKuCL.Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood2013;
121:1357–66
33.
PithukpakornMRoothumnongEAngkasekwinaiNSuktitipatBAssawamakinALuangwedchakarnVUmrodPThongnoppakhunWFoongladdaSSuputtamongkolY.HLA-DRB1 and HLA-DQB1 are associated with adult-onset immunodeficiency with acquired anti-interferon-gamma autoantibodies. PLoS One2015;
10:e0128481
34.
KuCLLinCHChangSWChuCCChanJFKongXFLeeCHRosenEADingJYLeeWIBustamanteJWitteTShihHPKuoCYChetchotisakdPKiertiburanakulSSuputtamongkolYYuenKYCasanovaJLHollandSMDoffingerRBrowneSKChiCY.Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across southeast Asia. J Allergy Clin Immunol2016;
137:945–8.e8
35.
van de VosseEvan WengenAvan der MeideWFVisserLGvan DisselJT.A 38-year-old woman with necrotising cervical lymphadenitis due to histoplasma capsulatum. Infection2017;
45:917–20
36.
YoshizawaKAokiAShimaKTanabeYKoyaTHasegawaTKikuchiTSakagamiT.Serum anti-interferon-gamma autoantibody titer as a potential biomarker of disseminated non-tuberculous mycobacterial infection. J Clin Immunol2020;
40:399–405
37.
NithichanonAChetchotisakdPMatsumuraTTakahashiYAtoMSakagamiTLertmemongkolchaiG.Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA. Sci Rep2020;
10:8968
38.
WuUIChuangYCShengWHSunHYJhongYTWangJYChangSCWangJTChenYC.Use of QuantiFERON-TB gold in-tube assay in screening for neutralizing anti-interferon-gamma autoantibodies in patients with disseminated nontuberculous mycobacterial infection. Clin Microbiol Infect2018;
24:159–65
39.
IkedaHNakamuraKIkenoriMSaitoTNagamineKInoueMSakagamiTSuzukiHUsuiMKanemitsuKMatsumotoAShinboT.Severe disseminated Mycobacterium avium infection in a patient with a positive serum autoantibody to interferon-γ. Intern Med2016;
55:3053–8
40.
ShimaKSakagamiTTanabeYAokiNMoroHKoyaTKagamuHHasegawaTSuzukiENaritaI.Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients. J Infect Chemother2014;
20:52–6
41.
DöffingerRHelbertMRBarcenas-MoralesGYangKDupuisSCeron-GutierrezLEspitia-PinzonCBarnesNBothamleyGCasanovaJLLonghurstHJKumararatneDS.Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis2004;
38:e10–4
LeeWIHuangJLWuTSLeeMHChenIJYuKHLiuCYYangCHHsiehMYLinYLShihYFJaingTHHuangSCKuoTTKuCL.Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian susceptibility to mycobacterial disease (MSMD) lacking bacille Calmette-Guerin (BCG)-induced diseases. Immunobiology2013;
218:762–71
44.
PatelSYDingLBrownMRLantzLGayTCohenSMartyakLAKubakBHollandSM.Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol2005;
175:4769–76
45.
RattanathammetheeKChawansuntatiKChaiwarithRPraparattanapanJSupparatpinyoKWipasaJ.Dot enzyme-linked immunosorbent assay strip as a screening tool for detection of autoantibody to interferon gamma in sera of suspected cases of adult-onset immunodeficiency. J Clin Lab Anal2018;
32:e22460
SuárezILehmannCGruellHGraebJKochanekMFätkenheuerGPlumGvan WengenAvan de VosseEHartmannPHanitschLGRybnikerJ.Repurposing QuantiFERON for detection of neutralizing interferon-γ autoantibodies in patients with nontuberculous mycobacterial infections. Clin Infect Dis2017;
65:518–21
48.
BurbeloPDBrowneSKSampaioEPGiacconeGZamanRKristosturyanERajanADingLChingKHBermanAOliveiraJBHsuAPKlimaviczCMIadarolaMJHollandSM.Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood2010;
116:4848–58
49.
KoyaTTsubataCKagamuHKoyamaKHayashiMKuwabaraKItohTTanabeYTakadaTGejyoF.Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother2009;
15:118–22
50.
BaerleckenNJacobsRStollMSchmidtREWitteT.Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis2009;
49:e76-8
51.
ChaononghinSVisuttichaikitSApisarnthanarakAKhawcharoenpornT.Disseminated Mycobacterium scrofulaceum infection in a patient with anti-interferon-gamma autoantibodies: a case report and review of the literature. Int J Mycobacteriol2020;
9:91–4
52.
KeragalaBGunasekeraCNYesudianPDGurugeCDissanayakaBSLiyanagamaDPJinadasaGIMConstantineSRHerathH.Disseminated Mycobacterium simiae infection in a patient with adult-onset immunodeficiency due to anti-interferon-gamma antibodies - a case report. BMC Infect Dis2020;
20:258
53.
HaseIMorimotoKSakagamiTKazumiYIshiiYvan IngenJ.Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-gamma neutralizing autoantibodies. J Infect Chemother2015;
21:468–72
54.
LiangXSiLLiYZhangJDengJBaiJLiMHeZ.Talaromyces marneffei infection relapse presenting as osteolytic destruction followed by suspected nontuberculous mycobacterium infection during 6 years of follow-up: a case update. Int J Infect Dis2020;
93:208–10
55.
WongkamhlaTChongtrakoolPJitmuangA.A case report of talaromyces marneffei oro-pharyngo-laryngitis: a rare manifestation of talaromycosis. BMC Infect Dis2019;
19:1034
56.
NeiTOkabeMMikamiIKoizumiYMaseHMatsudaKYamamotoTTakedaSTanakaKDanK.A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-gamma. Respir Med Case Rep2013;
8:10–3
57.
KoizumiYSakagamiTNishiyamaNHiraiJHayashiYAsaiNYamagishiYKatoHHagiharaMSakanashiDSuematsuHOgawaKMikamoH.Rituximab restores IFN-γ-STAT1 function and ameliorates disseminated Mycobacterium avium infection in a patient with anti-Interferon-γ autoantibody. J Clin Immunol2017;
37:644–9
58.
CzajaCAMerkelPAChanEDLenzLLWolfMLAlamRFrankelSKFischerAGogateSPerez-VelezCMKnightV.Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody. Clin Infect Dis2014;
58:e115–8
59.
PruetpongpunNKhawcharoenpornTDamronglerdPSuthiwartnarueputWApisarnthanarakARujanavejSSuwantaratN.Disseminated talaromyces marneffei and Mycobacterium abscessus in a patient with anti-Interferon-γ autoantibodies. Open Forum Infect Dis2016;
3:ofw093
60.
OchoaSDingLKreuzburgSTreatJHollandSMZerbeCS.Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-IFN-γ autoantibodies. Clin Infect Dis2020; DOI: 10.1093/cid/ciaa1086
61.
LaisuanWPisitkunPNgamjanyapornPSuangtamaiTRotjanapanP.Prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-γ autoantibodies. Open Forum Infect Dis2020;
7:35
